Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$0.64 - $3.15 $438 - $2,157
-685 Reduced 1.74%
38,705 $27,000
Q4 2022

Feb 10, 2023

BUY
$2.03 - $4.28 $4,277 - $9,017
2,107 Added 5.65%
39,390 $89,000
Q3 2022

Nov 08, 2022

BUY
$3.04 - $5.14 $18,230 - $30,824
5,997 Added 19.17%
37,283 $119,000
Q2 2022

Aug 10, 2022

BUY
$3.17 - $6.17 $14,873 - $28,949
4,692 Added 17.64%
31,286 $119,000
Q1 2022

May 02, 2022

BUY
$4.16 - $13.72 $5,736 - $18,919
1,379 Added 5.47%
26,594 $143,000
Q4 2021

Feb 03, 2022

SELL
$10.83 - $18.41 $1.48 Million - $2.52 Million
-136,829 Reduced 84.44%
25,215 $341,000
Q3 2021

Nov 10, 2021

BUY
$13.07 - $18.84 $37,340 - $53,825
2,857 Added 1.79%
162,044 $2.91 Million
Q2 2021

Aug 06, 2021

SELL
$16.52 - $20.4 $62,643 - $77,356
-3,792 Reduced 2.33%
159,187 $2.73 Million
Q1 2021

May 13, 2021

SELL
$16.56 - $25.46 $102,407 - $157,444
-6,184 Reduced 3.66%
162,979 $3.26 Million
Q4 2020

Feb 12, 2021

BUY
$15.77 - $19.03 $38,809 - $46,832
2,461 Added 1.48%
169,163 $2.88 Million
Q3 2020

Nov 13, 2020

BUY
$16.59 - $24.79 $45,257 - $67,627
2,728 Added 1.66%
166,702 $2.77 Million
Q2 2020

Aug 06, 2020

BUY
$16.86 - $23.44 $5,091 - $7,078
302 Added 0.18%
163,974 $3.8 Million
Q1 2020

May 11, 2020

BUY
$14.47 - $27.96 $60,730 - $117,348
4,197 Added 2.63%
163,672 $2.92 Million
Q4 2019

Feb 11, 2020

BUY
$15.87 - $23.12 $2.16 Million - $3.15 Million
136,035 Added 580.35%
159,475 $3.44 Million
Q3 2019

Nov 14, 2019

BUY
$16.91 - $36.27 $4,295 - $9,212
254 Added 1.1%
23,440 $427,000
Q2 2019

Aug 12, 2019

SELL
$31.0 - $36.3 $3,224 - $3,775
-104 Reduced 0.45%
23,186 $825,000
Q1 2019

May 13, 2019

BUY
$31.58 - $46.35 $3,631 - $5,330
115 Added 0.5%
23,290 $783,000
Q4 2018

Feb 12, 2019

BUY
$30.43 - $56.65 $29,730 - $55,347
977 Added 4.4%
23,175 $762,000
Q3 2018

Nov 13, 2018

BUY
$46.46 - $68.49 $67,506 - $99,515
1,453 Added 7.0%
22,198 $1.35 Million
Q2 2018

Aug 09, 2018

SELL
$46.25 - $104.45 $3.69 Million - $8.33 Million
-79,744 Reduced 79.36%
20,745 $1.01 Million
Q1 2018

May 11, 2018

BUY
$57.4 - $108.44 $2.22 Million - $4.19 Million
38,595 Added 62.36%
100,489 $10.7 Million
Q4 2017

Jan 31, 2018

BUY
$23.02 - $60.5 $1.42 Million - $3.74 Million
61,894
61,894 $3.7 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.